SERVICES*

Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Clinical Experience with the Fraxel SR Laser: 202 Treatments in 59 Consecutive Patients. *

Background: The authors investigated postprocedure patient satisfaction after fractional photothermolysis with the Fraxel SR laser.
 
Methods: All patients were surveyed with respect to their satisfaction with the results using a Likert scale ranging from 1 to 5, with 5 = extremely satisfied and 1 = extremely dissatisfied. Fraxel SR laser treatment was performed for categories of skin abnormalities that included dyschromia, scarring, and texture abnormalities. Most patients had more than one concern. Univariate and multivariate analyses were performed. Logistic regression was used to explore predictors of a satisfaction score of 4 or 5.
 
Results: Fifty-nine patients (median age, 52 years; range, 30 to 71 years) underwent Fraxel SR laser resurfacing and completed the survey. A total of 202 treatments (median, four; range, one to six) were performed. Seventy-five percent of all patients were very satisfied (4 or 5 rating) with treatment. Seventy-five percent with dyschromia, 74 percent with texture abnormalities, and 100 percent with scarring had a satisfaction score of 4 or 5. Multivariate analysis found scarring, four or more treatments, and age older than 56 years to be associated with a score of 4 or 5. The odds of giving a satisfaction score of 4 or 5 increased approximately two-fold for each additional treatment a patient received.
 
Conclusions: This study reports the largest experience to date with the clinical use of the Fraxel SR laser and is the first report of patient satisfaction after fractional photothermolysis. Patients reported high satisfaction rates for improvements in texture, dyschromia, and scarring.

* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 09-08-2008
Authors: Cohen, Steven R. M.D.; Henssler, Cory R.N.; Horton, Kelly; Broder, Kevin W. M.D.; Moise-Broder, Pamela A. Pharm.D.
Source: Plastic & Reconstructive Surgery. 121(5),:297e-304e, May 2008.